急诊经皮冠状动脉介入治疗术,Emergency percutaneous coronary artery intervention
1)Emergency percutaneous coronary artery intervention急诊经皮冠状动脉介入治疗术
英文短句/例句
1.Value of pre-PCI ECG parameters in predicting myocardial reperfusion level after emergency PCI急诊经皮冠状动脉介入治疗术前心电图参数对术后心肌再灌注水平的预测价值
2.Emergency percutaneous coronary interventional in treatment of 35 cases of acute myocardial infarction急诊经皮冠状动脉介入治疗急性心肌梗死35例
3.The clinical outcomes of Partner drug-eluting stent in emergent PCIPartner药物洗脱支架在急诊经皮冠状动脉介入治疗中的临床疗效
4.Transradial Approach for Diagnostic Coronary Angiography and Coronary Interventions;经皮穿刺桡动脉冠状动脉介入诊断与治疗
5.Clinical Study of Early Application of Intensive Atorvastatin in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention早期强化阿托伐他汀对急性冠脉综合征急诊经皮冠状动脉介入治疗预后的临床研究
6.Advantages and Shortcomings of Emergency Percutaneous Coronary Intervention with Transradial Access in Patients with Acute Myocardial Infarction经桡动脉急诊冠状动脉介入治疗急性心肌梗死的优势与不足
7.Feasibility of the transradial approach in primary percutaneous coronary intervention for acute myocardial infarction经桡动脉途径行急性心肌梗死急诊冠状动脉介入治疗的可行性
8.Efficiency of intra-aortic balloon pump combined with emergency percutaneous coronary intervention in patients with acute myocardial infarction complicated with cardiogenic shock主动脉气囊反搏联合急诊经皮冠状动脉介入治疗急性心肌梗死合并心源性休克
9.Facilitated Percutaneous Coronary Intervention(PCI)via Trans-radial Artery Approach in the Treatment of Acute Myocardial Infarction桡动脉途径易化经皮冠状动脉介入治疗急性心肌梗死效果观察
10.Influence of Admission Glucose Concentration on the Levels of CRP、MCP-1 Preoperative and Postoperative in Patients with Acute Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention;血糖对急性心肌梗死急诊经皮冠状动脉介入治疗前后CRP、MCP-1水平的影响
11.Factors of inducing low myocardial perfusion after percutaneous coronary intervention in acute ST-elevation myocardial infarction patients急性ST段抬高心肌梗死急诊经皮冠状动脉介入治疗后心肌灌注不良的影响因素
12.Contrast-induced nephropathy in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention急性心肌梗死患者急诊经皮冠状动脉介入治疗后对比剂肾病的研究
13.Effect of Prostaglandin E1 on Myocardial Perfusion in Patients with ST-segment Elevated Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention凯时对急性心肌梗死急诊经皮冠状动脉介入治疗后心肌灌注的影响
14.Percutaneous coronary intervention through transulnar approach:12 cases report经尺动脉径路行经皮冠状动脉介入治疗12例
15.Influence of Complications with Different Infarction Related Artery in PCI不同冠状动脉急性闭塞部位对急诊冠状动脉介入治疗术并发症的影响
16.The effect of atorvastatin pretreatment on oxygen free radical after reperfusion in patients undergoning primary percutaneous coronary interventions阿托伐他汀对急诊经皮冠状动脉介入治疗患者再灌注后氧自由基的影响
17.Emergent Percutaneous Transluminal Coronary Angioplasty in 41 Patients with Acute Myocardial Infarction in Elementary Hospital基层医院开展急诊经皮冠状动脉支架植入术治疗急性心肌梗死的可行性研究
18.Acute myocardial infarction with diabetes percutaneous coronary intervention and follow-up急性心肌梗死合并糖尿病患者的经皮冠状动脉介入治疗
相关短句/例句
Emergency percutaneous coronary intervention急诊经皮冠状动脉介入治疗
3)emergency percutaneous coronary intervention急诊冠状动脉介入治疗
1.Objective To assess the safety and values of tirofiban in the patients with acute ST-elevation myocardial infarction duringemergency percutaneous coronary intervention.目的:评估替罗非班用于急性ST段抬高心肌梗死患者急诊冠状动脉介入治疗时的安全性及临床疗效。
4)Acute left main coronary artery occlusion急诊经皮冠状动脉介入
5)percutaneous coronary intervention经皮冠状动脉介入治疗
1.Effect ofpercutaneous coronary intervention on late heart rate turbulence in patients with acute myocardial ischemia;经皮冠状动脉介入治疗对急性心肌梗死患者近期心率震荡的影响
2.Effects ofpercutaneous coronary intervention on left ventricular systolic function in patients with left ventricular dysfunction and chronic total occlusion;经皮冠状动脉介入治疗对冠状动脉慢性完全闭塞病变患者左心室重构及心功能的影响
3.Effect of Percutaneous coronary intervention(PCI)on the short-term prognosis of acute coronary syndrome;经皮冠状动脉介入治疗对急性冠脉综合征近期预后的影响
6)Percutaneous coronary intervention(PCI)经皮冠状动脉介入治疗
延伸阅读
经皮腔内冠状动脉成形术经皮腔内冠状动脉成形术percutaneoustranstuminalcoronaryangioplasty采用股动脉穿刺将球囊导管送至冠状动脉狭窄病变处，加压扩张以增大血管内径，改善心肌血供。英文简称PTCA。是1977年以后国际上冠心病介入性治疗的技术，也是治疗冠心病的主要方法之一。适应症根据临床表现分析PTCA的适应症：①药物治疗效果不佳的慢性稳定性心绞痛或不稳定性心绞痛，有明确的心肌缺血证据，左室的功能良好。②扩展的适应症：慢性稳定性心绞痛或不稳定性心绞痛伴多支血管病变；药物治疗有效的心绞痛，但运动试验阳性者；急性心肌梗死；冠脉搭桥术后心绞痛；高危心绞痛患者；变异型心绞痛但有严重的固定狭窄；PTCA术后再狭窄者。根据冠状动脉病变特性分析PTCA的适应症：1988年ACCAHAPTCA专家组总结了过去的经验，提出了冠状动脉病变特征与PTCA成功率的关系，可作为选择PTCA适应症的参考。相对禁忌症①无保护的左主干病变。②左主干等同病变。③冠状动脉病变狭窄程度＜50％者。④多支，广泛性弥漫性病变，PTCA成功可能性极小者。⑤陈旧的慢性完全闭塞病变。成功的标准①PTCA术后冠状动脉狭窄程度减少20％以上，残余狭窄＜50％。②无急性心肌梗死或需急诊冠脉搭桥术，无手术及院内死亡。合并症内膜撕裂；急性闭塞；边支闭塞；血栓形成及栓塞；冠脉痉挛；心律失常。缓慢型心律失常及各种室性心律失常。合并症的发生率为5％～10％，但其中80％～90％的病例经适当处理可获得满意的结果，转为成功的PTCA。成功率及追踪国际上PTCA的成功率已达90％～95％。中国为80％～85％，远期疗效亦为80％以上。其再狭窄率达30％～35％，多发生在术后6个月内，如稳定1年以上，则极少有再狭窄。对于再狭窄的患者，根据冠状动脉造影结果，可再次选择PTCA，成功率仍达90％以上，且再狭窄率降低。
